Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline On-demand PrEP vs PEP for Preventing STIs in MSM
NCT06188442Phase 4Active, not recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in sexually transmitted infection (STI), syphilis, gonorrhea, Chlamydia trachomatis infection (CT), sponsored by The Chinese University of Hong Kong. Started Mar 2025; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
sexually transmitted infection (STI)syphilisgonorrheaChlamydia trachomatis infection (CT)
Beyond the preview
Go deeper on NCT06188442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06188442.